Description

A biomarker is a biological characteristic that is objectively measured and evaluated as an indicator of normal biological or pathological processes, or a response to a therapeutic intervention. Examples include patterns of gene expression, levels of a particular protein in body fluids, or changes in electrical activity in the brain. The global biomarkers market is poised to grow by US$ 48.0 billion during 2022-2028, progressing at a CAGR of 12.3% during the forecast period, according to data and analytics company StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for biomarkers. The global biomarkers market is segmented on the basis of product, technology, disease, end user, and region. By product, the global biomarkers market has been segmented into consumables, instruments, services, software. In 2021, the consumables segment made up the largest share of revenue generated by the biomarkers market. Based upon technology, the global biomarkers market is categorized into genomics, proteomics, metabolomics, imaging, others. The proteomics segment was the largest contributor to the global biomarkers market in 2021. On the basis of disease, the global biomarkers market has been segmented into cancer, cardiovascular and metabolic diseases, neurodegenerative diseases, infectious diseases, autoimmune diseases, others. The cancer segment is estimated to account for the largest share of the global biomarkers market. By end user, the global biomarkers market has been segmented into biopharmaceutical and biotech companies, CROs, hospitals and diagnostics, research and academic institutes. The hospitals and diagnostics segment held the largest share of the global biomarkers market in 2021 and is anticipated to hold its share during the forecast period. Geographically, the global biomarkers market is segmented into Emerging Region, Europe, North America.

The global biomarkers market is highly competitive. The prominent players operating in the global biomarkers market include Abbott Laboratories, Agilent Technologies Inc., Bayer AG, Becton Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corp., Bruker Corp., Canon Medical Systems Corporation, Danaher Corporation, F. Hoffmann-La Roche Ltd, FUJIFILM VisualSonics Inc., GE Healthcare, Illumina Inc., JEOL Ltd., Koninklijke Philips N.V., Oxford Nanopore Technologies Limited, PerkinElmer Inc., QIAGEN N.V., Shimadzu Corporation, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Waters Corporation.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the biomarkers market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: consumables, instruments, services, software
Technology: genomics, proteomics, metabolomics, imaging, others
Disease: cancer, cardiovascular and metabolic diseases, neurodegenerative diseases, infectious diseases, autoimmune diseases, others
End user: biopharmaceutical and biotech companies, CROs, hospitals and diagnostics, research and academic institutes
Region: Emerging Region, Europe, North America
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global biomarkers market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Biomarkers market overview
Part 3. Market breakdown by product
– Consumables
– Instruments
– Services
– Software
Part 4. Market breakdown by technology
– Genomics
– Proteomics
– Metabolomics
– Imaging
– Others
Part 5. Market breakdown by disease
– Cancer
– Cardiovascular and metabolic diseases
– Neurodegenerative diseases
– Infectious diseases
– Autoimmune diseases
– Others
Part 6. Market breakdown by end user
– Biopharmaceutical and biotech companies
– CROs
– Hospitals and diagnostics
– Research and academic institutes
Part 7. Market breakdown by region
– Emerging Region
– Europe
– North America
Part 8. Key companies
– Abbott Laboratories
– Agilent Technologies Inc.
– Bayer AG
– Becton, Dickinson and Company
– Bio-Rad Laboratories, Inc.
– Bio-Techne Corp.
– Bruker Corp.
– Canon Medical Systems Corporation
– Danaher Corporation
– F. Hoffmann-La Roche Ltd
– FUJIFILM VisualSonics Inc.
– GE Healthcare
– Illumina, Inc.
– JEOL Ltd.
– Koninklijke Philips N.V.
– Oxford Nanopore Technologies Limited
– PerkinElmer, Inc.
– QIAGEN N.V.
– Shimadzu Corporation
– Siemens Healthineers AG
– Thermo Fisher Scientific Inc.
– Waters Corporation
About StrategyHelix
Disclaimer